Study on diagnosis and treatment of Budd-Chiari syndrome in China based on CO-word analysis_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

ZHANG Jiawei , CHEN Xiaoxiao ,  LU Zhaojun

Department of Epidemiology and Health Statistics, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221000, P. R. China;

Corresponding?author：

LU Zhaojun, Email: L23zj@163.com

Keywords：

Budd-Chiari syndrome; Co-word analysis; keyword network; frequency; research hotspot

DOI：

10.7507/1007-9424.201906040

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective The purpose of this study is to apply the method of CO-word analysis to the evidence-based study of the diagnosis and treatment of Budd-Chiari syndrome (BCS), to understand the trend of BCS research in China and to explore the hot spots of BCS in recent years, and to provide new evidence-based data for the clinical practice and experimental research of BCS in China.Methods In the Wanfang database, CNKI, and VIP retrieval platform, " Budd-Chiari syndrome” was used as the key word or title. According to the publication time, it was divided into before 1998 (study group 1), 1999–2008 (study group 2), and 2009–2018 years (study group 3). The relationship matrix was established by using the Netdraw tool in Ucinet6.0, and the common words were plotted with the Netdraw tool. The word relation network was used to get the analysis chart of the relation of the word.Results This study found that, Budd-Chiari syndrome, inferior vena cava, hepatic vein, inferior vena cava obstruction, and syndrome were the most frequently used keywords in the study group 1. Budd-Chiari syndrome, inferior vena cava, hepatic venous, interventional therapy, and patients were the most frequent keywords in the study group 2. In the study group 3, Budd-Chiari syndrome, interventional therapy, inferior vena cava, hepatic vein, and patient were the most frequent keywords.Conclusions Hepatic vein type and inferior vena cava type have became a research hotspot in recent years, and the thrombosis mechanism is one of the directions for domestic scholars to study the etiology of BCS. The diagnosis and classification of BCS depend on color doppler ultrasound technology. Many studies focus on the differential diagnosis of BCS and cirrhosis.

Citation： ZHANG Jiawei, CHEN Xiaoxiao, LU Zhaojun. Study on diagnosis and treatment of Budd-Chiari syndrome in China based on CO-word analysis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(1): 75-81. doi: 10.7507/1007-9424.201906040 Copy

1.	汪忠鎬, 李震. 布加綜合征診治歷史、現狀和發展趨勢. 中國實用外科雜志, 2015, 35(12): 1261-1263.
2.	Ollivier-Hourmand I, Allaire M, Goutte N, et al. The epidemiology of Budd-Chiari syndrome in France. Dig Liver Dis, 2018, 50(9): 931-937.
3.	Afredj N, Guessab N, Nani A, et al. Aetiological factors of Budd-Chiari syndrome in Algeria. World J Hepatol, 2015, 7(6): 903-909.
4.	Wu Y, Jin X, Xue Y. Evaluation of research topic evolution in psychiatry using co-word analysis. Medicine (Baltimore), 2017, 96(25): e7349.
5.	黨曉衛, 李路豪, 李林, 等. 布加綜合征臨床分型在其治療中的應用價值. 中華消化外科雜志, 2016, 15(7): 696-701.
6.	Liu L, Qi XS, Zhao Y, et al. Budd-Chiari syndrome: current perspectives and controversies. Eur Rev Med Pharmacol Sci, 2016, 20(15): 3273-3281.
7.	中國醫師協會腔內血管學專業委員會腔靜脈阻塞專家委員會. 布-加綜合征亞型分型的專家共識. 臨床肝膽病雜志, 2017, 33(7): 1229-1235.
8.	Khan F, Armstrong MJ, Mehrzad H, et al. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther, 2019, 49(7): 840-863.
9.	Qi X, Han G, Guo X, et al. Review article: the aetiology of primary Budd-Chiari syndrome-differences between the West and China. Aliment Pharmacol Ther, 2016, 44(11-12): 1152-1167.
10.	Okuda K. Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol, 2001, 16(11): 1179-1183.
11.	林薇, 曾維政, 湯善宏, 等. 布加綜合征病因學總結. 四川醫學, 2016, 37(6): 693-696.
12.	吳磊, 張雪, 陳啟鴻, 等. 磁共振成像與數字減影造影診斷布加綜合征下腔靜脈病變的比較. 中華肝膽外科雜志, 2017, 23(6): 361-364.
13.	Van Wettere M, Bruno O, Rautou PE, et al. Diagnosis of Budd-Chiari syndrome. Abdom Radiol (NY), 2018, 43(8): 1896-1907.
14.	李曦, 彭匯涓, 沙曉溪, 等. 彩色多普勒超聲在布-加綜合征診斷及分型中的價值. 川北醫學院學報, 2013, 28(4): 359-361.
15.	Hak JF, Dabadie A, Hery G, et al. Doppler ultrasound in the diagnosis of Budd-Chiari syndrome in children after split liver transplantation. Diagn Interv Imaging, 2018, 99(10): 663-668.
16.	管中華. 彩超檢測肝硬化與布-加綜合征的對比研究. 飲食保健, 2017, 4(14): 18-19.
17.	李震, 丁鵬緒, 汪忠鎬. 布加綜合征的規范化治療. 中國血管外科雜志: 電子版, 2013, 5(3): 27-29.
18.	He F, Zhao H, Dai S, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep, 2016, 6: 36380.
19.	黃崇青, 虞冠鋒, 黃景勇. 血管內介入治療肝后段下腔靜脈閉塞型布加綜合征1例. 浙江醫學, 2017, 39(14): 1223-1236.
20.	王朝陽, 任建莊, 韓新巍, 等. 經頸靜脈肝內門體分流術聯合經導管溶栓治療肝靜脈廣泛閉塞型巴德-吉亞利綜合征合并急性門靜脈血栓的臨床療效. 中華消化雜志, 2017, 37(10): 661-665.
21.	Kucukay F, Akdogan M, Bostanci EB, et al. Percutaneous transluminal angioplasty for complete membranous obstruction of suprahepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol, 2016, 39(10): 1392-1399.
22.	于士龍, 王徽, 林易圣, 等. 肝靜脈、下腔靜脈球囊擴張、支架置入術治療下腔靜脈閉塞型布-加綜合征. 實用醫學雜志, 2013, 29(22): 3681-3683.
23.	Wei X, Hao X, Da-Hai Y, et al. Analysis of interventional treatments of Budd-Chiari Syndrome and the related complications: a study of 1 006 cases. Panminerva Med, 2013, 55(4): 371-376.
24.	Khan F, Mehrzad H, Tripathi D. Timing of transjugular intrahepatic portosystemic stent-shunt in Budd-Chiari syndrome: a UK hepatologist’s perspective. J Transl Int Med, 2018, 6(3): 97-104.
25.	湯波, 余朝文, 唐文波. 肝靜脈下腔靜脈 CTV 成像在布加綜合征診斷與治療方式選擇中的價值. 中國普通外科雜志, 2016, 25(1): 143-146.
26.	Qi XS, Ren WR, Fan DM, et al. Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature. World J Gastroenterol, 2014, 20(30): 10628-10636.

1. 汪忠鎬, 李震. 布加綜合征診治歷史、現狀和發展趨勢. 中國實用外科雜志, 2015, 35(12): 1261-1263.
2. Ollivier-Hourmand I, Allaire M, Goutte N, et al. The epidemiology of Budd-Chiari syndrome in France. Dig Liver Dis, 2018, 50(9): 931-937.
3. Afredj N, Guessab N, Nani A, et al. Aetiological factors of Budd-Chiari syndrome in Algeria. World J Hepatol, 2015, 7(6): 903-909.
4. Wu Y, Jin X, Xue Y. Evaluation of research topic evolution in psychiatry using co-word analysis. Medicine (Baltimore), 2017, 96(25): e7349.
5. 黨曉衛, 李路豪, 李林, 等. 布加綜合征臨床分型在其治療中的應用價值. 中華消化外科雜志, 2016, 15(7): 696-701.
6. Liu L, Qi XS, Zhao Y, et al. Budd-Chiari syndrome: current perspectives and controversies. Eur Rev Med Pharmacol Sci, 2016, 20(15): 3273-3281.
7. 中國醫師協會腔內血管學專業委員會腔靜脈阻塞專家委員會. 布-加綜合征亞型分型的專家共識. 臨床肝膽病雜志, 2017, 33(7): 1229-1235.
8. Khan F, Armstrong MJ, Mehrzad H, et al. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther, 2019, 49(7): 840-863.
9. Qi X, Han G, Guo X, et al. Review article: the aetiology of primary Budd-Chiari syndrome-differences between the West and China. Aliment Pharmacol Ther, 2016, 44(11-12): 1152-1167.
10. Okuda K. Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol, 2001, 16(11): 1179-1183.
11. 林薇, 曾維政, 湯善宏, 等. 布加綜合征病因學總結. 四川醫學, 2016, 37(6): 693-696.
12. 吳磊, 張雪, 陳啟鴻, 等. 磁共振成像與數字減影造影診斷布加綜合征下腔靜脈病變的比較. 中華肝膽外科雜志, 2017, 23(6): 361-364.
13. Van Wettere M, Bruno O, Rautou PE, et al. Diagnosis of Budd-Chiari syndrome. Abdom Radiol (NY), 2018, 43(8): 1896-1907.
14. 李曦, 彭匯涓, 沙曉溪, 等. 彩色多普勒超聲在布-加綜合征診斷及分型中的價值. 川北醫學院學報, 2013, 28(4): 359-361.
15. Hak JF, Dabadie A, Hery G, et al. Doppler ultrasound in the diagnosis of Budd-Chiari syndrome in children after split liver transplantation. Diagn Interv Imaging, 2018, 99(10): 663-668.
16. 管中華. 彩超檢測肝硬化與布-加綜合征的對比研究. 飲食保健, 2017, 4(14): 18-19.
17. 李震, 丁鵬緒, 汪忠鎬. 布加綜合征的規范化治療. 中國血管外科雜志: 電子版, 2013, 5(3): 27-29.
18. He F, Zhao H, Dai S, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep, 2016, 6: 36380.
19. 黃崇青, 虞冠鋒, 黃景勇. 血管內介入治療肝后段下腔靜脈閉塞型布加綜合征1例. 浙江醫學, 2017, 39(14): 1223-1236.
20. 王朝陽, 任建莊, 韓新巍, 等. 經頸靜脈肝內門體分流術聯合經導管溶栓治療肝靜脈廣泛閉塞型巴德-吉亞利綜合征合并急性門靜脈血栓的臨床療效. 中華消化雜志, 2017, 37(10): 661-665.
21. Kucukay F, Akdogan M, Bostanci EB, et al. Percutaneous transluminal angioplasty for complete membranous obstruction of suprahepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol, 2016, 39(10): 1392-1399.
22. 于士龍, 王徽, 林易圣, 等. 肝靜脈、下腔靜脈球囊擴張、支架置入術治療下腔靜脈閉塞型布-加綜合征. 實用醫學雜志, 2013, 29(22): 3681-3683.
23. Wei X, Hao X, Da-Hai Y, et al. Analysis of interventional treatments of Budd-Chiari Syndrome and the related complications: a study of 1 006 cases. Panminerva Med, 2013, 55(4): 371-376.
24. Khan F, Mehrzad H, Tripathi D. Timing of transjugular intrahepatic portosystemic stent-shunt in Budd-Chiari syndrome: a UK hepatologist’s perspective. J Transl Int Med, 2018, 6(3): 97-104.
25. 湯波, 余朝文, 唐文波. 肝靜脈下腔靜脈 CTV 成像在布加綜合征診斷與治療方式選擇中的價值. 中國普通外科雜志, 2016, 25(1): 143-146.
26. Qi XS, Ren WR, Fan DM, et al. Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature. World J Gastroenterol, 2014, 20(30): 10628-10636.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Study on diagnosis and treatment of Budd-Chiari syndrome in China based on CO-word analysis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content